表纸
市场调查报告书

感染疾病诊断的全球市场 - 至2022年的预测:化验,套件、试剂,设备

Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User - Global Forecast to 2022

出版商 MarketsandMarkets 商品编码 322724
出版日期 内容资讯 英文 172 Pages
订单完成后即时交付
价格
感染疾病诊断的全球市场 - 至2022年的预测:化验,套件、试剂,设备 Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User - Global Forecast to 2022
出版日期: 2018年04月16日内容资讯: 英文 172 Pages
简介

全球感染疾病诊断市场,预计从2017年的147亿3000万美元,到2022年扩大到193亿5000万美元。预计市场2017年~2022年以5.6%的年复合成长率成长。

本报告提供全球感染疾病诊断市场相关调查分析,市场概要,产业趋势,各市场区隔的市场分析,竞争情形,主要企业等相关的系统性资讯。

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 重要考察

  • 感染疾病诊断:市场概要
  • 感染疾病诊断市场:各技术,各地区
  • 感染疾病诊断市场:各产品与服务
  • 感染疾病诊断市场:各终端用户

第5章 市场概要

  • 简介
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会

第6章 感染疾病诊断的全球市场:各产品与服务

  • 简介
  • 化验,套件、试剂
  • 设备
  • 服务,软体

第7章 感染疾病诊断的全球市场:各技术

  • 简介
    • 免疫诊断
    • 临床微生物学
    • 聚合酵素链锁反应 (PCR)
    • 恒温核酸增幅技术 (INAAT)
    • DNA定序,次世代定序 (NGS)
    • DNA微阵列
    • 其他

第8章 感染疾病诊断的全球市场:各疾病类型

  • 简介
    • 肝炎
    • 人免疫力缺乏病毒 (HIV)
    • 沙眼披衣菌感染疾病,淋病(CT,NG)
    • 院内感染 (HAIS)
    • 人类乳突病毒 (HPV)
    • 结核 (TB)
    • 流感
    • 其他

第9章 感染疾病诊断的全球市场:各终端用户

  • 简介
  • 医院/临床检验室
  • 参照实验室
  • 诊疗所
  • 学术/研究机关
  • 其他

第10章 感染疾病诊断的全球市场:各地区

  • 简介
  • 北美
  • 欧洲
  • 亚太地区
  • 其他

第11章 竞争情形

  • 市场概要
  • 市场排行榜分析
  • 竞争情形与趋势

第12章 企业简介

  • ABBOTT LABORATORIES
  • BECTON, DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES
  • DANAHER CORPORATION
  • DIASORIN
  • LUMINEX
  • MERIDIAN BIOSCIENCE
  • QUIDEL
  • ROCHE DIAGNOSTICS
  • SIEMENS AG
  • THERMO FISHER SCIENTIFIC

第13章 附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: MD 3088

"The global infectious disease diagnostics market is projected to grow at a CAGR of 5.6%."

The global infectious disease diagnostics market is expected to reach USD 19.35 billion by 2022 from USD 14.73 billion in 2017, at a CAGR of 5.6%. Growth in this market can primarily be attributed to factors such as increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics. However, inadequate reimbursement and rising healthcare cost limiting usage of novel diagnostic technologies are expected to restrain the growth of this market during the forecast period.

"The assays, kits, & reagents segment accounted for the largest share in 2017."

Based on product & service, the infectious disease diagnostics market is segmented into assays, kits, & reagents; instruments; and services & software. The assays, kits, and reagents segment accounted for the largest share of the global infectious disease diagnostics market in 2017. The large share of this segment can be attributed to the increasing number of infectious disease diagnostic tests carried out; easy accessibility to a wide range of reagents; and the growing need for reliable, specific, and faster detection of infectious diseases in the early stages.

"Asia Pacific is projected to grow at the highest CAGR during the forecast period."

Geographically, Asia Pacific is expected to register the highest CAGR during the forecast period. The growth of this regional segment can be attributed to the growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).

Break-up Profile of Primaries:

  • By Company Type- Tier 40%, Tier 30%, and Tier 30%
  • By Designation-C-level-27%, D-level-18%, and Others-55%
  • By Region-North America-50%, Europe-20%, Asia Pacific-20%, and RoW-10%

The key players in the global infectious disease diagnostics market are: Abbott (US), Becton, Dickinson and Company (BD) (US), bioMerieux (France), Bio-Rad (US), and Roche (Switzerland).

Research Coverage:

The infectious disease diagnostics market in this report is segmented by product & service, disease type, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches & approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and profiles key players and core competencies in the infectious disease diagnostics market.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on portfolios offered by the top players in the global infectious disease diagnostics market. The report analyzes the market by product & service, disease type, technology, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global infectious disease diagnostics market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for infectious disease diagnostic products across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global infectious disease diagnostics market
  • Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global infectious disease diagnostics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. PRIMARY DATA
    • 2.1.1. KEY DATA FROM PRIMARY SOURCES
    • 2.1.2. KEY INDUSTRY INSIGHTS
  • 2.2. SECONDARY DATA
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.4.1. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. INFECTIOUS DISEASE DIAGNOSTICS: MARKET OVERVIEW
  • 4.2. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY AND REGION (2017)
  • 4.3. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017 VS. 2022(USD BILLION)
  • 4.4. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing global prevalence of infectious diseases
      • 5.2.1.2. Shift in focus from centralized laboratories to decentralized point-of-care testing
      • 5.2.1.3. Growth in funding for research on infectious disease diagnostics
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Inadequate reimbursements
      • 5.2.2.2. Rising healthcare costs limiting the use of novel diagnostic techniques
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Advances in genomics and proteomics
      • 5.2.3.2. Growing awareness about personalized medicine
      • 5.2.3.3. Growth opportunities in emerging markets

6. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE

  • 6.1. INTRODUCTION
  • 6.2. ASSAYS, KITS, & REAGENTS
  • 6.3. INSTRUMENTS
  • 6.4. SERVICES & SOFTWARE

7. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
    • 7.1.1. IMMUNODIAGNOSTICS
    • 7.1.2. CLINICAL MICROBIOLOGY
    • 7.1.3. POLYMERASE CHAIN REACTION (PCR)
    • 7.1.4. ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
    • 7.1.5. DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS)
    • 7.1.6. DNA MICROARRAY
    • 7.1.7. OTHER TECHNOLOGIES

8. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE

  • 8.1. INTRODUCTION
    • 8.1.1. HEPATITIS
      • 8.1.1.1. Hepatitis diagnostics market, by technology
    • 8.1.2. HUMAN IMMUNODEFICIENCY VIRUS (HIV)
    • 8.1.3. CHLAMYDIA TRACHOMATIS GENITAL INFECTION AND GONORRHEA (CT/NG)
    • 8.1.4. HOSPITAL-ACQUIRED INFECTIONS (HAIS)
    • 8.1.5. HUMAN PAPILLOMAVIRUS (HPV)
    • 8.1.6. TUBERCULOSIS (TB)
      • 8.1.6.1. Tuberculosis diagnostics market, by technology
    • 8.1.7. INFLUENZA
      • 8.1.7.1. Influenza diagnostics market, by technology
    • 8.1.8. OTHER INFECTIOUS DISEASES

9. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITAL/CLINICAL LABORATORIES
  • 9.3. REFERENCE LABORATORIES
  • 9.4. PHYSICIAN OFFICES
  • 9.5. ACADEMIC/RESEARCH INSTITUTES
  • 9.6. OTHER END USERS

10. INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
  • 10.4. ASIA PACIFIC (APAC)
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. MARKET OVERVIEW
  • 11.2. MARKET RANKING ANALYSIS, 2017
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. PRODUCT LAUNCHES AND APPROVALS
    • 11.3.2. COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS
    • 11.3.3. ACQUISITIONS
    • 11.3.4. EXPANSIONS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. ABBOTT LABORATORIES
  • 12.2. BECTON, DICKINSON AND COMPANY
  • 12.3. BIOMERIEUX SA
  • 12.4. BIO-RAD LABORATORIES
  • 12.5. DANAHER CORPORATION
  • 12.6. DIASORIN
  • 12.7. LUMINEX
  • 12.8. MERIDIAN BIOSCIENCE
  • 12.9. QUIDEL
  • 12.10. ROCHE DIAGNOSTICS
  • 12.11. SIEMENS AG
  • 12.12. THERMO FISHER SCIENTIFIC

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: NEW TESTS LAUNCHED BY KEY PLAYERS
  • TABLE 2: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 3: INFECTIOUS DISEASE DIAGNOSTIC ASSAYS, KITS, & REAGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTIC ASSAYS, KITS, & REAGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 5: INFECTIOUS DISEASE DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 7: INFECTIOUS DISEASE DIAGNOSTIC SERVICES & SOFTWARE MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTIC SERVICES & SOFTWARE MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 10: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 12: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CLINICAL MICROBIOLOGY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CLINICAL MICROBIOLOGY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 14: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 16: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INAAT, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INAAT, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 18: DNA SEQUENCING & NGS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: NORTH AMERICA: DNA SEQUENCING & NGS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 20: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 22: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY DISEASE TYPE, 2015-2022 (USD MILLION)
  • TABLE 25: HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: HEPATITIS DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 27: HEPATITIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 28: HIV DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: HIV DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: CT/NG DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: NORTH AMERICA: CT/NG DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 32: HAI DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: NORTH AMERICA: HAI DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: HPV DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: HPV DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: TUBERCULOSIS DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 37: NORTH AMERICA: TUBERCULOSIS DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 38: TUBERCULOSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 39: INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 40: NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 41: INFLUENZA DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 42: OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 43: NORTH AMERICA: OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 44: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 45: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HOSPITAL/CLINICAL LABORATORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 46: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HOSPITAL/CLINICAL LABORATORIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 47: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 49: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PHYSICIAN OFFICES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 50: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PHYSICIAN OFFICES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 51: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ACADEMIC/RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 52: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ACADEMIC/RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 53: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 54: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD MILLION) 75  
  • TABLE 55: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 56: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 57: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 58: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 59: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 61: US: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 62: US: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 63: US: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: US: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 65: CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 66: CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 67: CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 70: EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 71: EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 72: EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2015-2022 (USD MILLION)
  • TABLE 73: EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 75: APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 76: APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 77: APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2015-2022 (USD MILLION)
  • TABLE 78: APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 80: ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 81: ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 82: ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2015-2022 (USD MILLION) 96  
  • TABLE 83: ROW: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 84: RANK OF COMPANIES IN THE GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET, 2017
  • TABLE 85: PRODUCT LAUNCHES, 2015-2018
  • TABLE 86: COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2015 & 2018
  • TABLE 87: ACQUISITIONS, 2015-2017
  • TABLE 88: EXPANSIONS, 2015 TO 2017

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION
  • FIGURE 6: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2017 VS. 2022
  • FIGURE 7: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2017 VS. 2022
  • FIGURE 8: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017 VS. 2022
  • FIGURE 9: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2017 VS. 2022
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE INFECTIOUS DISEASE DIAGNOSTICS MARKET
  • FIGURE 11: INCREASING PREVALENCE OF INFECTIOUS DISEASES IS A KEY DRIVER FOR THE INFECTIOUS DISEASE DIAGNOSTICS MARKET
  • FIGURE 12: IMMUNODIAGNOSTICS TECHNOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2017
  • FIGURE 13: ASSAYS, KITS & REAGENTS WILL CONTINUE TO DOMINATE THE INFECTIOUS DISEASE DIAGNOSTICS MARKET IN 2022
  • FIGURE 14: HOSPITALS & CLINICAL LABORATORIES ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 15: INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 16: ASSAYS, KITS, & REAGENTS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: IMMUNODIAGNOSTICS TO DOMINATE THE IDD MARKET DURING THE FORECAST PERIOD (2017-2022)
  • FIGURE 18: HEPATITIS DISEASE DIAGNOSTICS SEGMENT TO DOMINATE THE IDD MARKET DURING THE FORECAST PERIOD (2017-2022)
  • FIGURE 19: INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2022 (USD MILLION)
  • FIGURE 20: GEOGRAPHICAL SNAPSHOT: ASIA PACIFIC TO BE THE FASTEST-GROWING REGIONAL SEGMENT IN THE INFECTIOUS DISEASE DIAGNOSTICS MARKET
  • FIGURE 21: NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 22: ASIA PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 23: KEY DEVELOPMENTS IN THE INFECTIOUS DISEASE DIAGNOSTICS MARKET BETWEEN 2013 AND 2016
  • FIGURE 24: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 25: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017)
  • FIGURE 26: BIOMERIEUX SA: COMPANY SNAPSHOT (2016)
  • FIGURE 27: BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 28: DANAHER CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 29: DIASORIN: COMPANY SNAPSHOT (2017)
  • FIGURE 30: LUMINEX: COMPANY SNAPSHOT (2016) 136  
  • FIGURE 31: MERIDIAN BIOSCIENCE: COMPANY SNAPSHOT (2017)
  • FIGURE 32: QUIDEL: COMPANY SNAPSHOT (2016)
  • FIGURE 33: ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2017)
  • FIGURE 34: SIEMENS AG: COMPANY SNAPSHOT (2017)
  • FIGURE 35: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016)